Biosafety consequences of eradication of wild-type polioviruses

Lancet

Volumn 358, Issue 9277, 2001, Pages 166-168

  Minor, P D ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS B3; ENDEMIC DISEASE; HUMAN; IMMUNIZATION; MICROBIOLOGICAL EXAMINATION; NONHUMAN; NOTE; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; VACCINATION; VIROLOGY; VIRUS ISOLATION; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

EID: 0035928394     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05399-5     Document Type: Note

References (10)

1. Progress towards global poliomyelitis eradication, as of May 1999
2. The biologic principles of poliovirus eradication
3. Genetic analysis of wild-type poliovirus importation into The Netherlands (1979-1995)
4. The polio eradication effort: Should vaccine eradication be next?
5. The laboratory containment of wild poliovirus in Australia
6. th meeting
7. Stopping poliovirus vaccination after eradication: Issues and challenges